fig3

The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future

Figure 3. Weekly number of tests in pharmacies and general practitioners’ offices (A) and home data (C) collected before, during, and after the lockdown in Italy, and weekly frequency (%) of abnormal tests collected in the same settings and periods (B and D, respectively). Redrawn with permission[109].

Connected Health And Telemedicine
ISSN 2993-2920 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/